How to Build (and Regulate) A Body Part: Regulating Tissue Engineering in Canada
Bibliographic record
Abstract
Efforts to replace or repair human tissues go back hundreds of years, but recent developments in biomedical and engineering sciences have made possible a new generation of technologies, creating the multidisciplinary field of “tissue engineering.” Tissue engineered products for skin and cartilage are already on the market, and recent breakthroughs include the successful implantation of engineered bladders and tracheas, as well as progress toward engineering more complex organs like lungs and intestines. Most tissue engineering applications still require years of development and testing before they can be clinically useful, but these recent advances have generated a great deal of excitement. This technology promises great benefits for patients, but also raises some novel ethical, legal, and policy issues. In particular, tissue engineering presents significant challenges for regulatory agencies responsible for overseeing the safety, efficacy, and quality of medical products. Tissue engineered products involve the convergence of several novel technologies, all complex in themselves and interacting in significant and perhaps unpredictable ways with each other and with the human body into which the product will be implanted. The complexity and novelty of these products will make them difficult to classify and will stretch the limits of our existing knowledge about how to assess the safety and efficacy of medical products. It will therefore be important to consider the extent to which our current regulatory framework is adequate to deal with these new types of products, and examine recent developments elsewhere that might provide models for reform. The way that regulatory requirements will be applied under this framework is just as important, however, so we also need to consider the challenges involved in assessing the novel technologies used in tissue engineering and their interactions. Concerns that have been raised about the resources and expertise available to agencies like Health Canada and the U.S. Food and Drug Administration (FDA) are highly relevant in this context, since tissue engineered products will place significant demands on the regulatory agencies charged with reviewing them. After introducing the field of tissue engineering, this article will discuss these challenges, and assess the extent to which Canada’s regulatory framework is prepared to meet them.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.015 | 0.020 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.017 | 0.016 |
| Scholarly communication | 0.015 | 0.008 |
| Open science | 0.005 | 0.008 |
| Research integrity | 0.011 | 0.011 |
| Insufficient payload (model declined to judge) | 0.017 | 0.003 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".